As part of our mission to advance the knowledge and care of patients with cardiovascular disease and its risk factors, the TIMI Study Group has established Core Laboratories that lead the acquisition and analysis of ECG, biomarker, and genetic data in clinical research. With oversight by our world-renowned investigators, the TIMI Core Laboratories conduct quantitative assessments that serve either as the critical efficacy or safety endpoints, or as important exploratory parameters in clinical trials and epidemiological studies. These research activities contribute to the richly annotated clinical databases from TIMI studies.
An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School